## **Core Concept**
Enfuvirtide is an antiretroviral drug used in the treatment of HIV infection. It works by inhibiting the fusion of the virus with the host cell membrane. This class of drugs targets a specific step in the HIV life cycle.

## **Why the Correct Answer is Right**
Enfuvirtide belongs to the class of drugs known as **fusion inhibitors**. Fusion inhibitors block the entry of HIV into the host cell by inhibiting the fusion of the viral envelope with the host cell membrane. This is achieved by binding to the gp41 subunit of the HIV envelope glycoprotein, preventing the conformational change necessary for fusion. Enfuvirtide is a synthetic peptide that specifically targets this step, making it an effective agent in combination therapy for HIV.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because Enfuvirtide does not belong to the class of drugs known as **nucleoside reverse transcriptase inhibitors (NRTIs)**, which work by inhibiting the reverse transcription of viral RNA into DNA.
- **Option B:** This option is incorrect because Enfuvirtide is not a **protease inhibitor**, which block the protease enzyme that HIV uses to cleave viral polyproteins into functional proteins.
- **Option C:** This option might seem plausible but is not correct because Enfuvirtide is specifically known as a fusion inhibitor, not just broadly categorized under **entry inhibitors** which is a broader class that includes fusion inhibitors, CCR5 antagonists, and others.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Enfuvirtide must be administered via injection (subcutaneously) because it is a peptide and would be digested if taken orally. This makes it distinct from many other antiretroviral drugs that can be administered orally.

## **Correct Answer:** D. Fusion inhibitors.